The PrEP Care Continuum Among Cisgender Women Who Sell Sex and/or Use Drugs Globally: A Systematic Review.
Jennifer L GlickRienna RussoBelinda JivapongLori RosmanDanielle PelaezKatherine H A FooterSusan G ShermanPublished in: AIDS and behavior (2020)
HIV prevalence among cisgender female sex workers (FSW) and/or women who use drugs (WWUD) is substantially higher compared to similarly aged women. Consistent with PRISMA guidelines, we conducted the first systematic review on the pre-exposure prophylaxis (PrEP) continuum among FSW and/or WWUD, searching PubMed, Embase, CINAHL, PsycInfo, and Sociological Abstracts. Eligibility criteria included: reporting a PrEP related result among FSW and/or WWUD aged 18 + ; peer-reviewed; and published in English between 2012 and 2018. Our search identified 1365 studies; 26 met eligibility requirements, across the following groups: FSW (n = 14), WWUD (n = 9) and FSW-WWUD (n = 3). Studies report on at least one PrEP outcome: awareness (n = 12), acceptability (n = 16), uptake (n = 4), and adherence (n = 8). Specific barriers span individual and structural levels and include challenges to daily adherence, cost, and stigma. Combining health services and long-acting PrEP formulas may facilitate better PrEP uptake and adherence. The limited number of studies indicates a need for more research.
Keyphrases
- randomized controlled trial
- men who have sex with men
- hiv testing
- hiv positive
- meta analyses
- systematic review
- polycystic ovary syndrome
- pregnancy outcomes
- healthcare
- case control
- hiv aids
- mental health
- physical activity
- cervical cancer screening
- type diabetes
- palliative care
- risk factors
- adipose tissue
- emergency department
- hiv infected
- pregnant women
- human immunodeficiency virus
- clinical practice
- glycemic control
- chronic pain
- health insurance